Corticosteroids such as prednisone remain an effective tool for treating chronic graft-versus-host disease (cGVHD), although they are ineffective for many people and have troubling side effects—weight gain, bone loss, emotional disturbances—even when successful. Meanwhile, research into alternative treatments for cGVHD is well underway, according to a presentation at the HOPA Annual Conference 2024, in Tampa, Fla.
“Our goal